Related Experiment Video
Updated: Nov 15, 2025

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
Published on: January 17, 2025
Staphylococcus aureus Keratitis: Incidence, Pathophysiology, Risk Factors and Novel Strategies for Treatment
Jason W Lee1, Tobi Somerville2,3, Stephen B Kaye2,3
1School of Medicine, University of Liverpool, Liverpool L69 3GE, UK.
Abstract:
Bacterial keratitis is a devastating condition that can rapidly progress to serious complications if not treated promptly. Certain causative microorganisms such as Staphylococcus aureus and Pseudomonas aeruginosa are notorious for their resistance to antibiotics. Resistant bacterial keratitis results in poorer outcomes such as scarring and the need for surgical intervention. Thorough understanding of the causative pathogen and its virulence factors is vital for the discovery of novel treatments to avoid further antibiotic resistance. While much has been previously reported on P. aeruginosa, S. aureus has been less extensively studied. This review aims to give a brief overview of S. aureus epidemiology, pathophysiology and clinical characteristics as well as summarise the current evidence for potential novel therapies.
Insights
Staphylococcus aureus bacterial keratitis is a serious eye infection. This review explores novel therapies for antibiotic-resistant S. aureus eye infections, crucial for preventing vision loss.
Area of Science:
- Ophthalmology
- Microbiology
- Infectious Diseases
Background:
- Bacterial keratitis is a severe eye infection that can lead to vision loss.
- Antibiotic resistance in bacteria like Staphylococcus aureus complicates treatment.
- Pseudomonas aeruginosa is well-studied, but Staphylococcus aureus requires more research.
Purpose of the Study:
- To provide an overview of Staphylococcus aureus epidemiology, pathophysiology, and clinical features.
- To summarize current research on novel therapeutic strategies for S. aureus keratitis.
- To highlight the need for further investigation into S. aureus as a cause of resistant bacterial keratitis.
Main Methods:
- Literature review of studies on Staphylococcus aureus bacterial keratitis.
- Analysis of epidemiological data, virulence factors, and clinical presentations.
- Synthesis of evidence regarding emerging and potential novel treatments.
Main Results:
- Staphylococcus aureus is a significant cause of bacterial keratitis, often exhibiting antibiotic resistance.
- Virulence factors of S. aureus contribute to disease severity and treatment challenges.
- Existing treatments are becoming less effective due to rising resistance.
Conclusions:
- Understanding S. aureus in bacterial keratitis is vital for developing effective treatments.
- Novel therapeutic approaches are needed to combat antibiotic-resistant S. aureus eye infections.
- Further research into S. aureus pathogenesis and treatment is essential to improve patient outcomes.
More Related Videos
09:22Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis
Published on: May 12, 2020
06:36Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
Related Concept Videos
Angle Closure Glaucoma: Treatment
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Endocarditis I: Introduction
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...